CytoSorbents(CTSO) - 2024 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): January 3, 2025 Securities registered pursuant to Section 12(b) of the Act: CYTOSORBENTS CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-36792 98-0373793 (Commission File Number) (I.R.S. Employer Identification No.) (State or other jurisdiction of incorporation) 3 ...